These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 4957125

  • 1. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.
    Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE.
    Cancer Chemother Rep; 1966 May; 50(4):219-44. PubMed ID: 4957125
    [No Abstract] [Full Text] [Related]

  • 2. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA, Slavik M, Carter SK.
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [Abstract] [Full Text] [Related]

  • 3. Animal toxicology for early clinical trials with anticancer agents.
    Rozencweig M, Von Hoff DD, Staquet MJ, Schein PS, Penta JS, Goldin A, Muggia FM, Freireich EJ, DeVita VT.
    Cancer Clin Trials; 1981 May; 4(1):21-8. PubMed ID: 6783332
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV, Wang J, Lee FY, Marathe PH.
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man.
    Homan ER.
    Cancer Chemother Rep 3; 1972 May; 3(1):13-9. PubMed ID: 4626119
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL, Andrews PA, Smith DD, DeGeorge JJ, Justice RL, Beitz JG.
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ, McGovren JP, Dalm EA, Brewer JE, Hosley JD.
    Cancer Res; 1989 Nov 15; 49(22):6328-36. PubMed ID: 2529962
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents.
    Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR.
    Bioorg Med Chem Lett; 2006 Jan 01; 16(1):113-7. PubMed ID: 16216504
    [Abstract] [Full Text] [Related]

  • 18. Species differences in the disposition and metabolism of 6,11-dihydro-11-oxodibenz[be]oxepin-2-acetic acid (isoxepac) in rat, rabbit, dog, rhesus monkey, and man.
    Illing HP, Fromson JM.
    Drug Metab Dispos; 1978 Jan 01; 6(5):510-7. PubMed ID: 30600
    [Abstract] [Full Text] [Related]

  • 19. Toxicity and physiologic disposition of 2-amino-4',4"-bis(5-methyl-2-imidazolin-2-yl)terephthalanilide (NSC-66761).
    Philips FS, Sternberg SS, Cronin AP, Vidal PM.
    Cancer Chemother Rep; 1966 Jan 01; 50(1):9-23. PubMed ID: 4956044
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.